US Bancorp
ETON icon

US Bancorp’s Eton Pharmaceutcials ETON Stock Holding History

US Bancorp’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469 Sell
19
-35
-65% -$612 ﹤0.01% 4012
2025
Q4 		$913 Buy
+54
New +$950 ﹤0.01% 3869
2023
Q4 		– Sell
-805
Closed -$3.36K – 4034
2023
Q3 		$3.36K Buy
+805
New +$3.11K ﹤0.01% 3548

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

US Bancorp's ETON Position: Q1 2026 in Review

US Bancorp reduced its Eton Pharmaceutcials (ETON) stake by 65% in Q1 2026, selling an estimated $612 and leaving 19 shares worth $469. The position accounts for ﹤0.01% of the portfolio, ranked #4012.

US Bancorp first reported a position in ETON in Q3 2023 and has held it in 3 quarters since. The position peaked at $3.36K in Q3 2023. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • US Bancorp held 19 shares of Eton Pharmaceutcials worth $469 as of Q1 2026.
  • US Bancorp sold 35 Eton Pharmaceutcials shares in Q1 2026, an estimated $612.
  • Eton Pharmaceutcials made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #4012 holding.
  • US Bancorp first reported a position in Eton Pharmaceutcials in Q3 2023 and has held it in 3 quarters since.
  • US Bancorp's Eton Pharmaceutcials position peaked at $3.36K in Q3 2023.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.